Cassini receives KFDA clearance for South Korea

Cassini announced today that it has obtained approval to market the Cassini corneal shape analyzer in South Korea (ROK). This is another important milestone in the International expansion of Cassini.

Cassini to present at the Ophthalmology Futures Forum in Singapore

Cassini has received the distinction to present at the Ophthalmology Futures Asian Forum which is held on March 1st 2017 in Singapore. The event connects scientists, entrepreneurs, physicians, regulators, corporate leaders and venture capitalists to drive innovation within the eye-care market.

Cassini features among most promising private ophthalmology companies at Ophthalmology Innovation Summit (OIS@ASCRS) in New Orleans, LA

Mark Packer MD, Chief Medical Officer will highlight Cassini as core technology in today’s refractive cataract surgery ecosystem. Cassini enables seamless integration of clinic and operating suite, from preoperative diagnostics through visualization and laser applications to postoperative analysis. Cassini data demonstrate 94.0% reduction of astigmatism to target, 0.50 Diopter or less. These results help increase the adoption of premium cataract surgery and Advanced Technology IOL’s.

New Cassini Design to Light up Las Vegas

Redesigned Cassini corneal shape analyzer takes refractive-cataract surgery to a next level by measuring the total corneal astigmatism and eliminating post-op surprises